394 related articles for article (PubMed ID: 35355124)
1. Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus.
Oliveira CB; Kaplan MJ
Semin Immunopathol; 2022 May; 44(3):309-324. PubMed ID: 35355124
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
Liu Y; Yu X; Zhang W; Zhang X; Wang M; Ji F
J Autoimmun; 2022 Oct; 132():102863. PubMed ID: 35853760
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease in systemic lupus erythematosus: A comprehensive update.
Giannelou M; Mavragani CP
J Autoimmun; 2017 Aug; 82():1-12. PubMed ID: 28606749
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease in systemic lupus erythematosus: an update.
Liu Y; Kaplan MJ
Curr Opin Rheumatol; 2018 Sep; 30(5):441-448. PubMed ID: 29870498
[TBL] [Abstract][Full Text] [Related]
5. Vascular damage in systemic lupus erythematosus.
Ambler WG; Kaplan MJ
Nat Rev Nephrol; 2024 Apr; 20(4):251-265. PubMed ID: 38172627
[TBL] [Abstract][Full Text] [Related]
6. Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus.
Moore S; Juo HH; Nielsen CT; Tyden H; Bengtsson AA; Lood C
J Rheumatol; 2020 Nov; 47(11):1652-1660. PubMed ID: 31839592
[TBL] [Abstract][Full Text] [Related]
7. Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.
Reiss AB; Jacob B; Ahmed S; Carsons SE; DeLeon J
Inflammation; 2021 Oct; 44(5):1663-1682. PubMed ID: 33821395
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerosis in Systemic Lupus Erythematosus.
Tobin R; Patel N; Tobb K; Weber B; Mehta PK; Isiadinso I
Curr Atheroscler Rep; 2023 Nov; 25(11):819-827. PubMed ID: 37768411
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review.
Benvenuti F; Gatto M; Larosa M; Iaccarino L; Punzi L; Doria A
Expert Opin Drug Saf; 2015; 14(9):1373-85. PubMed ID: 26212119
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis in systemic lupus erythematosus.
Croca S; Rahman A
Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):364-372. PubMed ID: 29224678
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities.
Mauro D; Nerviani A
Rev Recent Clin Trials; 2018; 13(3):192-198. PubMed ID: 29542419
[TBL] [Abstract][Full Text] [Related]
12. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.
Somers EC; Zhao W; Lewis EE; Wang L; Wing JJ; Sundaram B; Kazerooni EA; McCune WJ; Kaplan MJ
PLoS One; 2012; 7(5):e37000. PubMed ID: 22606325
[TBL] [Abstract][Full Text] [Related]
13. Immune mechanisms associated with cardiovascular disease in systemic lupus erythematosus: A path to potential biomarkers.
Guzmán-Martínez G; Marañón C;
Front Immunol; 2022; 13():974826. PubMed ID: 36420265
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review.
Schoenfeld SR; Kasturi S; Costenbader KH
Semin Arthritis Rheum; 2013 Aug; 43(1):77-95. PubMed ID: 23422269
[TBL] [Abstract][Full Text] [Related]
15. Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus.
Tumurkhuu G; Montano E; Jefferies C
Curr Rheumatol Rep; 2019 Jul; 21(9):46. PubMed ID: 31338604
[TBL] [Abstract][Full Text] [Related]
16. [High cardiovascular complications in systemic lupus erythematosus: physiopathology and risk management].
Boffa JJ; Rougier JP; Noël N; Ronco P
Nephrol Ther; 2009 Dec; 5(7):595-602. PubMed ID: 19733524
[TBL] [Abstract][Full Text] [Related]
17. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.
Gustafsson JT; Svenungsson E
Autoimmunity; 2014 Mar; 47(2):67-76. PubMed ID: 24228980
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention.
Kostopoulou M; Nikolopoulos D; Parodis I; Bertsias G
Curr Vasc Pharmacol; 2020; 18(6):549-565. PubMed ID: 31880245
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease in lupus: insights and updates.
Knight JS; Kaplan MJ
Curr Opin Rheumatol; 2013 Sep; 25(5):597-605. PubMed ID: 23846339
[TBL] [Abstract][Full Text] [Related]
20. Cardiac and vascular complications in lupus: Is there a role for sex?
Corker A; Learmonth M; Patrick DM; DeLeon-Pennell KY; Van Beusecum JP
Front Immunol; 2023; 14():1098383. PubMed ID: 37063843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
